Gene · 715
Papers2,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review. | Front Oncol | 2023 | 37091170 | PubTator, text mining | PubMed |
| Complement Activation by Adeno-Associated Virus-Neutralizing Antibody Complexes. | Hum Gene Ther | 2023 | 37082966 | PubTator, text mining | PubMed |
| Integrated glycoproteomic characterization of clear cell renal cell carcinoma. | Cell Rep | 2023 | 37074911 | PubTator, text mining | PubMed |
| Characteristics and management of thrombotic microangiopathy in kidney transplantation. | Korean J Transplant | 2023 | 37064766 | PubTator, text mining | PubMed |
| New insights into the immune functions of podocytes: the role of complement. | Mol Cell Pediatr | 2023 | 37059832 | PubTator, text mining | PubMed |
| Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. | J Clin Invest | 2023 | 37053016 | PubTator, text mining | PubMed |
| Astaxanthin supplementation counters exercise-induced decreases in immune-related plasma proteins. | Front Nutr | 2023 | 37025615 | PubTator, text mining | PubMed |
| Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics. | Front Immunol | 2023 | 37020564 | PubTator, text mining | PubMed |
| Serpin family proteins as potential biomarkers and therapeutic drugs in stroke: A systematic review and meta-analysis on clinical/preclinical studies. | CNS Neurosci Ther | 2023 | 37017398 | PubTator, text mining | PubMed |
| SARS-CoV-2 Receptors and Their Involvement in Cell Infection. | Biochem (Mosc) Suppl Ser A Membr Cell Biol | 2023 | 37008884 | PubTator, text mining | PubMed |
| Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target. | Front Immunol | 2023 | 37006238 | PubTator, text mining | PubMed |
| New insight of complement system in the process of vascular calcification. | J Cell Mol Med | 2023 | 37002701 | PubTator, text mining | PubMed |
| Functionally distinct BMP1 isoforms show an opposite pattern of abundance in plasma from non-small cell lung cancer subjects and controls. | PLoS One | 2023 | 36989217 | PubTator, text mining | PubMed |
| MASP3 Deficiency in Mice Reduces but Does Not Abrogate Alternative Pathway Complement Activity Due to Intrinsic Profactor D Activity. | J Immunol | 2023 | 36988282 | PubTator, text mining | PubMed |
| Shedding Lights on the Extracellular Vesicles as Functional Mediator and Therapeutic Decoy for COVID-19. | Life (Basel) | 2023 | 36983995 | PubTator, text mining | PubMed |
| Molecular Alterations in Cutaneous Squamous Cell Carcinoma in Immunocompetent and Immunosuppressed Hosts-A Systematic Review. | Cancers (Basel) | 2023 | 36980718 | PubTator, text mining | PubMed |
| LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1. | Biomolecules | 2023 | 36979356 | PubTator, text mining | PubMed |
| Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2? | Biology (Basel) | 2023 | 36979076 | PubTator, text mining | PubMed |
| Complement C3 mediates podocyte injury through TLR4/NFΚB-P65 signaling during ischemia-reperfusion acute kidney injury and post-injury fibrosis. | Eur J Med Res | 2023 | 36973754 | PubTator, text mining | PubMed |
| Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. | Nat Commun | 2023 | 36973268 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/715/papers?page=15